Amylyx Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q4 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q3 2024.
  • Amylyx Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -139 %.
  • Amylyx Pharmaceuticals, Inc. annual Operating Margin for 2023 was 10.2K %.
  • Amylyx Pharmaceuticals, Inc. annual Operating Margin for 2022 was -906 %, a 96.9% increase from 2021.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -139 Jul 1, 2024 Sep 30, 2024
Q2 2024 -59.5 Apr 1, 2024 Jun 30, 2024
Q1 2024 -20.4 Jan 1, 2024 Mar 31, 2024
Q4 2023 10.2 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.